ADRIAMYCIN, CYCLOPHOSPHAMIDE AND VINDESINE (ACV) VERSUS MITOXANTRONE, CYCLOPHOSPHAMIDE AND VINDESINE (NCV) IN ADVANCED BREAST-CANCER

被引：0

作者：

JANSSENS, JP

CHIN, Y

DELEU, M

BONTE, J

STAELENS, Y

机构：

[1] LIMBURGS ONCOL CTR,HASSELT GENK,BELGIUM

[2] CATHOLIC UNIV LEUVEN,DEPT GYNECOL ONCOL,B-3000 LOUVAIN,BELGIUM

[3] DIENST ONCOL H HARTZIEKENHUIS,TIENEN,BELGIUM

来源：

ANTICANCER RESEARCH | 1993年 / 13卷 / 6B期

关键词：

ADVANCED BREAST CANCER; ADRIAMYCIN; MITOXANTRONE; COMBINATION CHEMOTHERAPY;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The choice of chemotherapy for advanced breast cancer patients is based on both response rates and anticipated side effects. Two polychemotherapy regimens, ACV and NCV, were compared in an open study with 90 patients of whom 69 were evaluable both for efficacy and toxicity. Both ACV and NCV are active in metastatic breast cancer. ACV lends to more remissions in a relatively short time. NCV treatment results in a larger proportion of stable diseases. ACV causes more important alopecia, nausea and vomiting. NCV gives more anemia. The characteristics of both treatment results give the oncologist the opportunity to choose in particular clinical situations.

引用

页码：2477 / 2483

页数：7

共 50 条

[21] CYCLOPHOSPHAMIDE, MITOXANTRONE AND FLUOROURACIL VERSUS CYCLOPHOSPHAMIDE, MITOXANTRONE AND FLUOROURACIL PLUS LONIDAMINE FOR THE TREATMENT OF ADVANCED BREAST-CANCER - A MULTICENTRIC RANDOMIZED CLINICAL-TRIAL
LORUSSO, V
CATINO, A
BRANDI, M
PIANO, A
PALOMBA, G
FORCIGNANO, R
MAZZOTTA, S
MUSCA, F
SERRAVEZZA, G
DURINI, E
CONTILLO, A
PEZZELLA, G
PALAZZO, S
CHETRI, C
DELENA, M
[J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1994, 4 : 767 - 772
[22] Randomised phase II study of epirubicin-vindesine versus mitoxantrone-vindesine in metastatic breast cancer
Hausmaninger, H
Lehnert, M
Steger, G
Sevelda, P
Tschurtschenthaler, G
Hehenwarter, W
Fridrik, M
Samonigg, H
Schiller, L
Manfreda, D
Haidinger, R
Kienzer, R
Kemmler, G
[J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A (13-14) : 2169 - 2173
[23] PROSPECTIVE RANDOMIZED STUDY WITH CROSSOVER IN METASTATIC BREAST-CANCER - MITOXANTRONE PLUS VINDESINE VERSUS 4'-EPIDOXORUBICIN PLUS VINDESINE AND MITOXANTRONE PLUS PREDNIMUSTINE VERSUS 4'-EPIDOXORUBICIN PLUS PREDNIMUSTINE
LEHNERT, M
HAUSMANINGER, H
LENZHOFER, R
[J]. ONKOLOGIE, 1987, 10 (05): : 276 - 277
[24] 5-DAY CONTINUOUS INFUSION OF 5 FLUOROURACIL WITH VINDESINE AND CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST-CANCER
POUILLART, P
PALANGIE, T
SCHOLL, S
BELLI, L
BEUZEBOC, P
JOUVE, M
DORVAL, T
GARCIAGIRALT, E
LIVARTOWSKI, A
BASTIAN, G
VEDRENNE, J
[J]. BULLETIN DU CANCER, 1989, 76 (02) : 191 - 195
[25] CHEMOHORMONAL THERAPY FOR ADVANCED BREAST-CANCER WITH TAMOXIFEN, ADRIAMYCIN, AND CYCLOPHOSPHAMIDE (TAC)
AHMANN, FR
JONES, SE
MOON, TE
HAMMOND, N
MILLER, TP
DURIE, BGM
[J]. CANCER, 1985, 56 (04) : 730 - 737
[26] A RANDOMIZED TRIAL OF ADRIAMYCIN, CYCLOPHOSPHAMIDE, FTORAFUR(ACF) AND ADRIAMYCIN, CYCLOPHOSPHAMIDE, FTORAFUR, METHOTREXATE (ACFM) IN PATIENTS WITH ADVANCED BREAST-CANCER
INOUE, K
OGAWA, M
INAGAKI, J
HORIKOSHI, N
MIYAMOTO, H
IKEDA, K
USUI, N
NAKADA, H
ADACHI, K
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 13 (02) : 95 - 99
[27] PROLONGED REMISSIONS INDUCED BY THE VINDESINE, MITOXANTRONE, MITOMYCIN COMBINATION IN METASTATIC BREAST-CANCER
DELPOMME, D
COUR, V
GISSELBRECHT, C
LEROL, A
MIGNOT, L
MARTY, M
GODEFFROY, W
MARAL, J
[J]. PRESSE MEDICALE, 1987, 16 (13): : 635 - 635
[28] VINDESINE IN THE TREATMENT OF METASTATIC BREAST-CANCER
HANSEN, PV
BRINCKER, H
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (10): : 1221 - 1225
[29] COMBINATION CHEMOTHERAPY FOR ADVANCED BREAST-CANCER UTILIZING VINCRISTINE, ADRIAMYCIN, AND CYCLOPHOSPHAMIDE (VAC)
RAINEY, JM
JONES, SE
SALMON, SE
[J]. CANCER, 1979, 43 (01) : 66 - 71
[30] CYCLOPHOSPHAMIDE, ADRIAMYCIN AND PLATINUM (CAP) IN DISSEMINATED BREAST-CANCER
AVERSA, SM
FORNASIERO, A
DANIELE, O
GHIOTTO, C
MORANDI, P
FIORENTINO, MV
[J]. TUMORI, 1986, 72 (06) : 686 - 686

← 1 2 3 4 5 →